Publications:

---

Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications

Boström, Martin M; Larsson, Erik E

Publication Date: 2022-11-17

Variant appearance in text: ERBB2: A20T

PubMed Link: 36396655

Variant Present in the following documents:

• 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page

---

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses.

Frontiers In Molecular Biosciences

Green-Tripp, Gabriela G; Nattress, Callum C; Halldén, Gunnel G

Publication Date: 2022

Variant appearance in text: HER2: A20T

PubMed Link: 35813830

Variant Present in the following documents:

• Main text
• fmolb-09-901392.pdf

View BVdb publication page

---

A chemoresistance lncRNA signature for recurrence risk stratification of colon cancer patients with chemotherapy.

Molecular Therapy. Nucleic Acids

Wang, Hao H; Gao, Yuzhen Y; Vafaei, Somayeh S; Yu, Qiaoyan Q; Zhang, Jun J; Wang, Liangjing L

Publication Date: 2022-03-08

Variant appearance in text: HER2: A20T

PubMed Link: 35036055

Variant Present in the following documents:

• mmc2.pdf

View BVdb publication page

---

A genomic mutation spectrum of collecting duct carcinoma in the Chinese population.

Bmc Medical Genomics

Zhang, Huaru H; Lu, Xiaojun X; Huang, Gang G; Hua, Meimian M; Zhang, Wenhui W; Wang, Tao T; Huang, Liqun L; Wang, Ziwei Z; Chen, Qing Q; Li, Jing J; Yang, Qing Q; Yang, Guosheng G

Publication Date: 2022-01-03

Variant appearance in text: ERBB2: A20T

PubMed Link: 34980126

Variant Present in the following documents:

• 12920_2021_1143_MOESM10_ESM.xlsx, sheet 2

View BVdb publication page

---

Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns.

Jco Precision Oncology

Lee, Jessica K JK; Madison, Russell R; Classon, Anthony A; Gjoerup, Ole O; Rosenzweig, Mark M; Frampton, Garrett M GM; Alexander, Brian M BM; Oxnard, Geoffrey R GR; Venstrom, Jeffrey M JM; Awad, Mark M MM; Schrock, Alexa B AB

Publication Date: 2021

Variant appearance in text: ERBB2: A20T

PubMed Link: 34476332

Variant Present in the following documents:

• po-5-po.21.00122.pdf

View BVdb publication page

---

High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.

Nature Communications

Zhang, Yiqun Y; Chen, Fengju F; Fonseca, Nuno A NA; He, Yao Y; Fujita, Masashi M; Nakagawa, Hidewaki H; Zhang, Zemin Z; Brazma, Alvis A; , ; , ; Creighton, Chad J CJ; ,

Publication Date: 2020-02-05

Variant appearance in text: ERBB2: A20T

PubMed Link: 32024823

Variant Present in the following documents:

• 41467_2019_13885_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

---

The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab.

Biomolecules

Shin, Jung Won JW; Kim, Soohyun S; Ha, Suji S; Choi, Byungsan B; Kim, Seongyeong S; Im, Seock-Ah SA; Yoon, Tae-Young TY; Chung, Junho J

Publication Date: 2019-10-19

Variant appearance in text: HER2: A20T

PubMed Link: 31635022

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis.

Biomed Research International

Ma, Yao Y; Feng, Xiao-Fei XF; Yang, Wan-Xia WX; You, Chong-Ge CG

Publication Date: 2019

Variant appearance in text: ERBB2: A20T

PubMed Link: 31534952

Variant Present in the following documents:

• BMRI2019-1093815.pdf

View BVdb publication page

---

Application of cell-free DNA for genomic tumor profiling: a feasibility study.

Oncotarget

Ahlborn, Lise B LB; Rohrberg, Kristoffer S KS; Gabrielaite, Migle M; Tuxen, Ida V IV; Yde, Christina W CW; Spanggaard, Iben I; Santoni-Rugiu, Eric E; Nielsen, Finn C FC; Lassen, Ulrik U; Mau-Sorensen, Morten M; Østrup, Olga O

Publication Date: 2019-02-15

Variant appearance in text: ERBB2: A20T

PubMed Link: 30858924

Variant Present in the following documents:

• oncotarget-10-1388-s002.xls, sheet 5

View BVdb publication page

---

Loss and gain of N-linked glycosylation sequons due to single-nucleotide variation in cancer.

Scientific Reports

Fan, Yu Y; Hu, Yu Y; Yan, Cheng C; Goldman, Radoslav R; Pan, Yang Y; Mazumder, Raja R; Dingerdissen, Hayley M HM

Publication Date: 2018-03-12

Variant appearance in text: ERBB2: A20T

PubMed Link: 29531238

Variant Present in the following documents:

• 41598_2018_22345_MOESM3_ESM.xlsx, sheet 1
• 41598_2018_22345_MOESM7_ESM.xlsx, sheet 1

View BVdb publication page

---

Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.

Scientific Reports

Kiss, Bernhard B; Wyatt, Alexander W AW; Douglas, James J; Skuginna, Veronika V; Mo, Fan F; Anderson, Shawn S; Rotzer, Diana D; Fleischmann, Achim A; Genitsch, Vera V; Hayashi, Tetsutaro T; Neuenschwander, Maja M; Buerki, Christine C; Davicioni, Elai E; Collins, Colin C; Thalmann, George N GN; Black, Peter C PC; Seiler, Roland R

Publication Date: 2017-02-16

Variant appearance in text: ERBB2: A20T

PubMed Link: 28205537

Variant Present in the following documents:

View BVdb publication page

---

CanDrA: cancer-specific driver missense mutation annotation with optimized features.

Plos One

Mao, Yong Y; Chen, Han H; Liang, Han H; Meric-Bernstam, Funda F; Mills, Gordon B GB; Chen, Ken K

Publication Date: 2013

Variant appearance in text: ERBB2: A20T

PubMed Link: 24205039

Variant Present in the following documents:

• pone.0077945.s001.xls, sheet 11

View BVdb publication page

---